Recruiting
Phase 2

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT06377566

Conditions

Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Brentuximab vedotin

Doxorubicin

Vinblastine

Dacarbazine

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information